Low-dose IL-2( Interleukin-2) Treatment in SLE
NCT02084238
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
Interleukin-2
Sponsor
Peking University People's Hospital
Collaborators
[object Object]